These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8395294)

  • 1. Effect of delayed weaning on opioid receptor control of swim stress-induced antinociception in the developing rat.
    Muhammad BY; Kitchen I
    Br J Pharmacol; 1993 Jul; 109(3):651-4. PubMed ID: 8395294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of preweanling chronic naltrindole administration on stress-induced antinociceptive responses in rats.
    Antelo MT; Fernández B; Kitchen I; Viveros MP
    Brain Res Dev Brain Res; 1998 Sep; 110(1):127-30. PubMed ID: 9733946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of swim-stress-induced antinociception by the delta-opioid receptor antagonist naltrindole in adult and young rats.
    Kitchen I; Pinker SR
    Br J Pharmacol; 1990 Aug; 100(4):685-8. PubMed ID: 2169936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of maternal milk on functional activation of delta-opioid receptors in postnatal rats.
    Goody RJ; Kitchen I
    J Pharmacol Exp Ther; 2001 Mar; 296(3):744-8. PubMed ID: 11181901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swim-stress-induced antinociception in young rats.
    Jackson HC; Kitchen I
    Br J Pharmacol; 1989 Mar; 96(3):617-22. PubMed ID: 2720296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats.
    Crook TJ; Kitchen I; Hill RG
    Br J Pharmacol; 1992 Oct; 107(2):573-6. PubMed ID: 1330187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of neonatal naltrindole treatment on antinociceptive and behavioral responses to mu and kappa agonists in rats.
    Fernández B; Antelo MT; Kitchen I; Viveros MP
    Pharmacol Biochem Behav; 1999 Jan; 62(1):145-9. PubMed ID: 9972857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS).
    Kalra A; Urban MO; Sluka KA
    J Pharmacol Exp Ther; 2001 Jul; 298(1):257-63. PubMed ID: 11408550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that weaning stimulates the developmental expression of a delta-opioid receptor subtype in the rat.
    Kitchen I; Crook TJ; Muhammad BY; Hill RG
    Brain Res Dev Brain Res; 1994 Mar; 78(1):147-50. PubMed ID: 8004769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of opioid receptors in oxytocin-induced antinociception in the nucleus accumbens of rats.
    Gu XL; Yu LC
    J Pain; 2007 Jan; 8(1):85-90. PubMed ID: 17097925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress-induced analgesia in mu-opioid receptor knockout mice reveals normal function of the delta-opioid receptor system.
    LaBuda CJ; Sora I; Uhl GR; Fuchs PN
    Brain Res; 2000 Jun; 869(1-2):1-5. PubMed ID: 10865052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrical stimulation at traditional acupuncture sites in periphery produces brain opioid-receptor-mediated antinociception in rats.
    Chen XH; Geller EB; Adler MW
    J Pharmacol Exp Ther; 1996 May; 277(2):654-60. PubMed ID: 8627542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta-opiod receptor-mediated forced swimming stress-induced antinociception in the formalin test.
    Kamei J; Hitosugi H; Misawa M; Nagase H; Kasuya Y
    Psychopharmacology (Berl); 1993; 113(1):15-8. PubMed ID: 7862822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring delta-receptor function using the selective opioid antagonist naltrindole.
    Jackson HC; Ripley TL; Nutt DJ
    Neuropharmacology; 1989 Dec; 28(12):1427-30. PubMed ID: 2559353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the leucopyrokinin analogue: [2-8]-leucopyrokinin on central opioid receptors in rats.
    Rykaczewska-Czerwińska M; Konopińska D; Plech A
    Comp Biochem Physiol C Toxicol Pharmacol; 2001 Nov; 130(3):271-9. PubMed ID: 11701384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception.
    Su YF; McNutt RW; Chang KJ
    J Pharmacol Exp Ther; 1998 Dec; 287(3):815-23. PubMed ID: 9864259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonist effects of beta-funaltrexamine and naloxonazine on alfentanil-induced antinociception and muscle rigidity in the rat.
    Negus SS; Pasternak GW; Koob GF; Weinger MB
    J Pharmacol Exp Ther; 1993 Feb; 264(2):739-45. PubMed ID: 8437122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediation of swim-stress antinociception by the opioid delta 2 receptor in the mouse.
    Vanderah TW; Wild KD; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1992 Jul; 262(1):190-7. PubMed ID: 1320682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouse.
    Jinsmaa Y; Fujita Y; Shiotani K; Miyazaki A; Li T; Tsuda Y; Okada Y; Ambo A; Sasaki Y; Bryant SD; Lazarus LH
    Eur J Pharmacol; 2005 Feb; 509(1):37-42. PubMed ID: 15713427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.